Company Outline

Company Name Olympus Corporation
Established October 12, 1919
President and Representative Director Hiroyuki Sasa
Head Office Shinjuku Monolith, 3-1 Nishi-Shinjuku 2-chome, Shinjuku-ku, Tokyo 163-0914, Japan

Map

Business Lines Manufacture and sales of precision machineries and instruments
Capital 124.5 billion yen (As of March 31, 2017)
Consolidated Net Sales 748.1 billion yen (Fiscal year ended March 31, 2017)
Consolidated Headcount 34,687 (As of March 31, 2017)

Share of Net Sales by Business Segment (Unit: Billions of Yen)

Fiscal year ended March 2017: Total 748.1 billion Yen, Medical Systems 575.3 billion Yen (76.9%), Scientific Solutions 93.2 billion Yen (12.5%), Camera and Audio 65.6 billion Yen (8.8%). Medical Systems Net Sales Breakdown: Endoscopes 322.9 billion Yen, Surgical Devices 182.6 billion Yen, Endo Therapy Devices 69.7 billion Yen.

The largest business segment is the medical systems, makes up over 70% of our net sales.

We deliver the diagnostic and therapeutic technologies such as gastrointestinal endoscopes, surgical endoscopy systems, and other peripherals, covering early diagnosis to minimally invasive therapy to provide the best possible outcomes for patients and society.

See Olympus Medical Business for details opens in new window

Number of Group Companies

Number of Group Companies: 108 (Excluding Olympus Corporation and including nonconsolidated subsidiaries and equity-method affiliates.)

Net Sales and Operating Income

FY ended March 2013 (Net Sales 743.9 billion Yen, Operating Income 35.1 billion Yen), FY ended March 2014 (Net Sales 713.3 billion Yen, Operating Income 73.4 billion Yen), FY ended March 2015 (Net Sales 764.7 billion Yen, Operating Income 91 billion Yen), FY ended March 2016 (Net Sales 804.6 billion Yen, Operating Income 104.5 billion Yen), FY ended March 2017 (Net Sales 748.1 billion Yen, Operating Income 765 billion Yen)

Net Sales by Region (Unit: Billions of Yen)

Fiscal year ended March 2017: Total 748.1 billion Yen, Japan 21.3%, North America 34.2%, Europe 23.4%, Asia Pacific 19.2%, Other Region 1.9%.